Video Shorts

How employers can navigate GLP-1 coverage costs

Real transparency means data plus an educational partner when it comes to drug costs

Transcranial magnetic stimulation is not electroconvulsive therapy

High deductibles make ACA enrollees question insurance value

Anti-sanctuary policies linked to rising HIV rates in Hispanic communities

The vicious cycle of sleep and ADHD

Why non-network health plans leave patients unprotected

Patient choice and policy advocacy go hand in hand in HIV prevention

Hyperactive-impulsive behaviors top indicators for ADHD preschoolers

Look for these signs if you suspect your child has narcolepsy

Helping beneficiaries meet Medicaid work rules

Preventing Medicaid loss through community support

Can better patient care and financial sustainability actually go hand in hand?

The crisis in rare disease medication access

Rex Hoffman, M.D., MBA ahead of the Health System Executive Summit

Will Carroll, Pharm.D., outlines Sutter Health's three pillars for care

Pharma's role in Medicaid Work Requirements

A deeper look at why auditory hallucinations occur

Why young adults should be cautious of cannabis legalization

Having a medical condition alone won't exempt enrollees from Medicaid work rules

Can cannabis use trigger schizophrenia?

Policymakers need better incentives to keep biosimilar development on track

IRA should target drugs unlikely to face biosimilar competition

Reducing prenatal inflammation may help offset child ADHD risk

IRA drug price negotiation could discourage biosimilar development

Early sensitive caregiving protective against ADHD symptoms in children

HIV prevention efforts continues despite latest funding barriers

The ‘horrible choices’ public health departments are forced to make | AIDS 2026

Why injectable PrEP isn’t for everyone | AIDS 2026

MK-8527 could expand monthly HIV prevention options